Citi Resumes Sensei Biotherapeutics (SNSE) at Buy, ‘Initial SNS-101 Efficacy Data at ASCO Suggest Early Clinical Activity’

Visit StreetInsider.com at http://www.streetinsider.com/New+Coverage/Citi+Resumes+Sensei+Biotherapeutics+%28SNSE%29+at+Buy%2C+%27Initial+SNS-101+Efficacy+Data+at+ASCO+Suggest+Early+Clinical+Activity%27/23312470.html for the full story.